⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Meiji Seika Pharma and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Meiji Seika Pharma
↗Tokyo, Japan
Meiji Seika Pharma is a core subsidiary of Meiji Holdings, specializing in the research, development, and manufacturing of ethical pharmaceuticals. The company is a recognized leader in Japan for infectious disease treatments, including antibiotics and vaccines, while also maintaining a strong presence in central nervous system (CNS) disorders and generic medicines.
Beyond its core pharmaceutical business, the company integrates its expertise with the broader Meiji Group's food and wellness capabilities. It actively engages in open innovation and strategic partnerships to advance its pipeline in oncology, immunology, and rare diseases, leveraging both small molecule and advanced modality platforms.
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Infectious Disease, CNS, Immunology
SIZE & FINANCIALS
Employees:5001-10000
Revenue:$7B-$8B
Founded:1916
Ownership:subsidiary
Status:operating
STOCK
Exchange:Tokyo Stock Exchange (via Parent: Meiji Holdings)
Ticker:2269
Market Cap:$6.16B
PIPELINE
Stage:Phase 3
Lead Drug Stage:Phase 3 (Nacubactam)
Modalities:Small molecule, mAb, mRNA vaccine
Active Trials:15
Trial Phases:Phase 1: 1 | Phase 3: 2
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Meiji Holdings
Subsidiaries:Medreich, ARCALIS
Key Partnerships:Arcturus Therapeutics (mRNA vaccines), Foundation for Biomedical Research and Innovation at Kobe (Immunology), Eisai (CNS)
COMPETITION
Position:Leader
Competitors:Shionogi, Daiichi Sankyo, Takeda, Eisai
LEADERSHIP
Key Executives:
Haruo Naito - CEO (Meiji Holdings)
LINKS
Website:meiji.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Meiji Seika Pharma. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.